AzTrials
AzTrials

Depression, PostpartumPhase 2/3NCT00251342

Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale

A Phase 2/3 study testing Edinburgh Postnatal Depression Scale in people with Depression, Postpartum, run by Chinese University of Hong Kong at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of the present study is to evaluate the effectiveness of postnatal depression screening by comparing the mental health outcome (at 6 months postpartum) of mothers under the Edinburgh Postnatal Depression Scale (EPDS) screening programme versus usual clinical practice (usual practice), using randomized… Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Depression, Postpartum
What is being tested?
Edinburgh Postnatal Depression Scale
Type of treatment
Surgery or procedure
How many people
460 participants
Where
1 siteChina
Study dates
Oct 2005to Jan 2008
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Chinese mothers of newborn babies <= 2 months who are registered with the 4 Maternal and Child Health Centres under study;
  • Normally resident in Hong Kong (Hong Kong ID card holder, or HK Birth Certificate [with status of permanent resident indicated established] holder, or people who have been granted unconditional stay in Hong Kong, or passport holders having valid travel document showing the right to land in Hong Kong, or permission to land, or eligibility of HK permanent ID card verified, or entitlement to the right of abode in HK)

Who cannot join

  • Those who do not use the Chinese language (in both the written and spoken form);
  • Those who are under active psychiatric contact;
  • Those who delivered in hospitals which are still conducting their own EPDS screening programme.

Trial locations and contacts

1 site in 1 country.

Cynthia Leung contact

fhssro@dh.gov.hk

China1 site, 1 recruiting
  • Maternal and Child Health Centres, Department of Health

    Hong Kong

    Cynthia Leung, fhssro@dh.gov.hk

    Recruiting

Other trials in China

About this study

The objective of the present study is to evaluate the effectiveness of postnatal depression screening by comparing the mental health outcome (at 6 months postpartum) of mothers under the Edinburgh Postnatal Depression Scale (EPDS) screening programme versus usual clinical practice (usual practice), using randomized controlled trial design. With the use of the EPDS for the screening of postnatal depression, it is expected that more mothers in need of intervention (including mental health intervention, guidance in childcare and parenting, counseling in family relationships, etc) will be picked up and offered appropriate intervention, compared to the usual practice. It is hypothesized that the mental health of the group of women under the EPDS screening programme will be better than those under the usual practice, on subsequent follow-up.

Being tested
Edinburgh Postnatal Depression Scale
Keywords
Postnatal depression, Randomized controlled trial, Screening, Outcome, Edinburgh Postnatal Depression Scale
Medical subject headings
Depression, Postpartum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Edinburgh Postnatal Depression ScaleProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mother's mental health at 6 months postpartum, as measured on the EPDS and General Health Questionnaire-12 (GHQ-12), both being self-report questionnaires.

Secondary outcomes (5)
  1. Mother's parenting stress (measured by the Parenting Stress Index, a self-report questionnaire)

  2. Marital relationship satisfaction (measured by the Chinese Kansas Marital Satisfaction Scale, a self-report questionnaire)

  3. Marital status and employment status (both father and mother, where applicable) at 6 and 18 months postpartum

  4. Child health measures, including weight at 6 and 18 months, number of hospitalizations and visits to doctors within the first 6 and 18 months as reported by mother

  5. Mother's mental health outcome (EPDS and GHQ scores) at 18 months postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2005 (estimated)
  2. Study startOct 2005
  3. Study completionJan 2008 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Enrolment
460 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00251342
Sponsor's protocol ID
CRE-2005.224-T
Other IDs
CUHK_CCT00019
Status last verified
Apr 2007
First submitted
9 Nov 2005
Last updated
5 Apr 2007
Results posted
No
Data monitoring committee
No

Publications

  • Leung SS, Leung C, Lam TH, Hung SF, Chan R, Yeung T, Miao M, Cheng S, Leung SH, Lau A, Lee DT. Outcome of a postnatal depression screening programme using the Edinburgh Postnatal Depression Scale: a randomized controlled trial. J Public Health (Oxf). 2011 Jun;33(2):292-301. doi: 10.1093/pubmed/fdq075. Epub 2010 Sep 29.

    PubMed 20884642

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Edinburgh Postnatal Depression Scale in people with Depression, Postpartum, run by Chinese University of Hong Kong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Cynthia Leung (fhssro@dh.gov.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mother's mental health at 6 months postpartum, as measured on the EPDS and General Health Questionnaire-12 (GHQ-12), both being self-report questionnaires.. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00251342, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2007.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in